UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________________ to ______________________ Commission File Number 000-23186 BIOCRYST PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) D ...

Call Start: 08:30 January 1, 0000 9:24 AM ET BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2022 Earnings Conference Call May 5, 2022 08:30 AM ET Company Participants John Bluth - SVP, IR and Corporate Communications Jon Stonehouse - Chief Executive Officer Anthony Doyle - Chief Financial Officer Dr. Bill Sheridan - Chief Medical Officer Charlie Gayer - Chief Commercial Officer Dr. Helen Thackray - Chief R&D Officer Conference Call Participants Ken Cacciatore - Cowen and Company Jon Wolleben - JMP Securiti ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number 000-23186 BIOCRYST PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of in ...

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2021 Results Conference Call February 23, 2022 8:30 AM ET Company Participants John Bluth - SVP, IR and Corporate Communications Jon Stonehouse - Chief Executive Officer Anthony Doyle - Chief Financial Officer Charlie Gayer - Chief Commercial Officer Dr. Helen Thackray - Chief R&D Officer Conference Call Participants Ken Cacciatore - Cowen and Company Tazeen Ahmad - Bank of America Jessica Fye - JPMorgan Chris Raymond - Piper Sandler Liisa Bayko - Evercore ISI ...

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q3 2021 Earnings Conference Call November 3, 2021 8:30 AM ET Company Participants John Bluth - SVP, IR and Corporate Communications Jon Stonehouse - Chief Executive Officer Anthony Doyle - Chief Financial Officer Charlie Gayer - Chief Commercial Officer Bill Sheridan - Chief Medical Officer Helen Thackray - Chief R&D Officer Conference Call Participants Tazeen Ahmad - Bank of America Brian Cheng - Cantor Fitizgerald Liisa Bayko - Evercore ISI Stacy Ku - Cowen & C ...